TCF7 and acute lymphoblastic leukemia: Taken together, our results suggest that TCF7/LEF1 activation underlies improved clinical performance within immature (ETP/Near-ETP) T-ALL, highlighting complex and functionally significant transcriptional regulatory circuits that underlie minute, single-marker immunophenotypical differences.